We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Richard
Lee
richard.lee@rmh.nhs.uk
SOPHIE
BETTERIDGE
octo-scoot@oncology.ox.ac.uk
Malignant neoplasms of respiratory and intrathoracic organs
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Lung Cancer is the second most common Cancer in the UK and the most lethal. Unfortunately, more than 75% of lung cancers in the UK are diagnosed late, and the 5-year survival rate for these patients is very low (5%).
Recently blood tests have been thought to be helpful in diagnosing lung cancer, and in this study we plan to take blood from patients that have a nodule suspected of being cancer (5000 patients). Taking blood samples from these patients will allow SCOOT to test if blood biomarkers can be used to help to predict whether a detected nodule suspected of being a lung cancer is cancerous or not.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Clinical Laboratory Study;
You can take part if:
You may not be able to take part if:
There are no exclusion criteria
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
The study is sponsored by University of Oxford and funded by Innovate UK .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 52228
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
